Unknown

Dataset Information

0

Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages.


ABSTRACT: The G protein-coupled receptor GPR55 has been proposed as a new cannabinoid receptor associated with bone remodelling, nervous system excitability, vascular homeostasis as well as in several pathophysiological conditions including obesity and cancer. However, its physiological role and underlying mechanism remain unclear. In the present work, we demonstrate for the first time its presence in human macrophages and its increased expression in ox-LDL-induced foam cells. In addition, pharmacological activation of GPR55 by its selective agonist O-1602 increased CD36- and SRB-I-mediated lipid accumulation and blocked cholesterol efflux by downregulating ATP-binding cassette (ABC) transporters ABCA1 and ABCG1, as well as enhanced cytokine- and pro-metalloprotease-9 (pro-MMP-9)-induced proinflammatory responses in foam cells. Treatment with cannabidiol, a selective antagonist of GPR55, counteracted these pro-atherogenic and proinflammatory O-1602-mediated effects. Our data suggest that GPR55 could play deleterious role in ox-LDL-induced foam cells and could be a novel pharmacological target to manage atherosclerosis and other related cardiovascular diseases.

SUBMITTER: Lanuti M 

PROVIDER: S-EPMC4430319 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages.

Lanuti Mirko M   Talamonti Emanuela E   Maccarrone Mauro M   Chiurchiù Valerio V  

PloS one 20150513 5


The G protein-coupled receptor GPR55 has been proposed as a new cannabinoid receptor associated with bone remodelling, nervous system excitability, vascular homeostasis as well as in several pathophysiological conditions including obesity and cancer. However, its physiological role and underlying mechanism remain unclear. In the present work, we demonstrate for the first time its presence in human macrophages and its increased expression in ox-LDL-induced foam cells. In addition, pharmacological  ...[more]

Similar Datasets

| S-EPMC5526182 | biostudies-literature
| S-EPMC5264135 | biostudies-literature
| S-EPMC4458544 | biostudies-other
| S-EPMC7287307 | biostudies-literature
| S-EPMC1186693 | biostudies-other
| S-EPMC3307646 | biostudies-literature
| S-EPMC2781710 | biostudies-literature
| S-EPMC8167864 | biostudies-literature
| S-EPMC4511354 | biostudies-literature
| S-EPMC3640261 | biostudies-literature